万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
常温,避光
- 克隆性:
单克隆
- 抗体名:
(MERS-CoV) Spike protein抗体
Antibody Type : Rabbit Polyclonal Antibody ( Antibody Purification Platform )
抗体宿主 : Rabbit IgG
缓冲液 : 0.2 μm filtered solution in PBS, 5% trehalose may be added in some batches. Please read the hardcopy of COA or contact our customer service to confirm the formulation.
制备方法 : Produced in rabbits immunized with purified, recombinant novel coronavirus (MERS-CoV) Spike Protein (Catalog#40069-V08B; AFS88936.1; Met1-Trp1297). Spike Protein specific IgG was purified by Novel coronavirus (MERS-CoV) Spike Protein affinity chromatography.
(MERS-CoV) Spike protein抗体 Background
The spike protein is one of the four major structural proteins of the coronavirus. Coronavirus symptoms include rhinorrhea, sneezing, cough, nasal obstruction, bronchitis and so on. In 2003, a novel coronavirus which is known as SARS coronavirus cause the severe acute respiratory syndrome (SARS) epidemic that began in Asia in 2002. Coronavirus entry is mediated by the viral spike protein. The 180-kDa oligomeric spike protein of the murine coronavirus mouse hepatitis virus strain A59 is posttranslationally cleaved into an S1 receptor binding unit and an S2 membrane fusion unit. Both biochemical and functional data show that the coronavirus spike protein is a class I viral fusion protein.
HCoV-EMC is a novel coronavirus isolated from a Saudi patient presenting with pneumonia and renal failure in June 2012. Genome sequencing showed that this virus belongs to the group C species of the genus betacoronavirus and phylogenetically related to the bat coronaviruses HKU4 and HKU5 previously found in lesser bamboo bat and Japanese Pipistrelle bat of Hong Kong respectively. HCoV-EMC has been identified as a highly lethal virus that could be passed from animals to humans very easily. The virus, like other coronaviridae, has the potential to infect bats and pigs in addition to humans. HCoV-EMC is related to the causative agent of SARS (severe acute respiratory syndrome), SARS coronavirus. and also may be even more infectious as it does not use the human receptor protein ACE2. The receptor used by HCov-EMC has not been identified. Symptoms of infection include kidney failure and severe pneumonia. The animal source has still not been identified but may circulate among populations of bats.
(MERS-CoV) Spike protein抗体相关产品如下:xy-3393R Phospho-SIRT1(Ser47)磷酸化沉默调节蛋白1抗体
xy-1298R Smac线粒体促凋亡蛋白抗体
xy-11784R SPR墨蝶蛉还原酶抗体
xy-11787R alpha + beta Synuclein核突触蛋白α+β抗体
xy-11671R SPFH2内质网脂质转运相关蛋白2抗体
xy-11673R Serine racemase丝氨酸消旋酶
xy-11754R SCGN钙结合样蛋白/神经内分泌肿瘤标记物抗体
xy-11755R SFRS7丝氨酸/苏氨酸蛋白激酶SRPK7抗体
xy-11756R SGSH磺氨基葡糖硫酸胺酶抗体
xy-11757R SMUBP2免疫球蛋白μ链结合蛋白2抗体
xy-11785R SPG21痉挛性截瘫相关蛋白21抗体
xy-11759R SPG3AG蛋白结合蛋白3抗体
xy-11760R SPG48SPG48蛋白抗体
xy-11761R SPG7痉挛性截瘫蛋白7/基质细胞粘附调节蛋白抗体
xy-11762R SPTBN2非红细胞血影脑蛋白β2/spectrin β III抗体
xy-11763R SULT4A1脑磺基转移酶样蛋白4A1抗体
xy-11765R Synaptotagmin-14突触结合蛋白14抗体
xy-11766R TBPTATA结合蛋白TBP抗体
xy-11767R TBCE微管蛋白特定伴侣蛋白E抗体
xy-11768R TDRD3Tudor结构域蛋白TDRD3抗体
xy-11769R TIMM8A线粒体内膜转位酶8A/耳聋/肌张力障碍肽抗体
xy-11770R TMEM158跨膜蛋白158抗体
xy-11771R TTBK2Tau微管蛋白激酶2抗体
xy-11773R Transglutaminase 6谷氨酰胺转胺酶6抗体
xy-11648R TMEM59L跨膜蛋白59样蛋白抗体
xy-11775R Twinkle共济失调蛋白8抗体
xy-11603R TBR1TBR1蛋白抗体
xy-11605R TULP3感光细胞转录因子TULP3抗体
xy-11607R TsukushinTSK蛋白抗体
xy-11614R TAS2R5味觉受体蛋白家族2亚基5抗体
xy-11674R TPPP微管蛋白聚合促进蛋白24
xy-11068R Tenascin R腱糖蛋白R抗体
xy-6425R TRP12瞬时受体电位蛋白12抗体
xy-12320R TCTN2结构蛋白家族2抗体
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Expression, Glycosylation, and Modification of the Spike (S) Glycoprotein of SARS CoV
The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. To study the maturation pathway of the S glycoprotein of the severe acute respiratory
Severe acute respiratory syndrome (SARS) coronavirus (CoV) contains a spike (S) protein that binds to a receptor molecule (angiotensin-converting enzyme 2; ACE2), induces membrane fusion, and serves as a neutralizing epitope. To study
中科院高福院士课题组 2020 年发表了哪些重要的研究成果?
年,高福院士和他带领的团队,在传染病研究领域尤其是对新冠病毒的研究,获得了丰厚的研究成果。其带领团队先后研发出新冠病毒治疗性中和抗体和疫苗,在新冠病毒溯源、跨种传播机制方面也有着突出的研究成果。 图片来源:Web of Science以下,小编选取了其中 10 项,介绍高福院士及其团队在 2020 年最有代表性的研究成果。 1、揭示 MERS-CoV 与 7 种蝙蝠 CD26 结合的分子基础DOI: 10.1128/JVI.01387-19自 2012 年鉴定出中东呼吸综合征冠状病毒(MERS-CoV
技术资料暂无技术资料 索取技术资料




